台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.8
  • 漲跌
    ▼1.3
  • 漲幅
    -2.09%
  • 成交量
    33
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-元大-內湖 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-內湖 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/250.161.5000.0061.500.1900.06%
2024/12/0900.000.166.6066.40-0.194-0.11%
2024/12/0300.000.165.0065.60-0.197-0.10%
2024/11/14171.00171.5069.7001020.00%
2024/11/1200.00286.0086.00-290-2.22%
2024/10/220.196.8000.0096.600.11360.09%
2024/10/0900.00197.3097.40-1138-0.72%
2024/10/0800.00097.0097.000138-0.01%
2024/10/0700.000.197.6096.80-0.1138-0.07%
2024/09/25097.7000.0097.7001380.01%
2024/09/2300.00096.8096.4001380.00%
2024/08/1900.000106.50106.0001300.00%
2024/08/1500.001103.00102.50-1114-0.87%
2024/08/1200.001103.00102.50-199-1.01%
2024/08/091101.5000.00100.501931.07%
2024/08/0800.003103.50105.00-395-3.14%
2024/08/073107.501108.00108.002972.04%
2024/08/0500.00198.6098.80-189-1.11%
2024/07/100.1102.0000.00101.000.1990.10%
2024/06/250.1101.0000.00101.000.11370.04%
2024/06/1200.002100.50101.00-2155-1.29%
2024/05/280.8103.0000.00102.500.81580.47%
2024/05/150103.5000.00104.0001480.01%
2024/05/1400.001101.00102.00-1144-0.69%
2024/05/130.6107.0000.00107.000.61270.45%
2024/05/101118.5000.00118.5011200.83%
2024/05/061118.5000.00119.0011180.84%
2024/05/020.2118.0000.00118.000.21160.17%
2024/04/290117.5000.00117.5001160.01%
2024/04/240.1118.0000.00118.000.11150.09%
2024/04/170.1117.0000.00117.000.11110.09%
2024/04/151.3116.8000.00117.001.31071.16%
2024/04/120.1118.0000.00118.000.11040.10%
2024/04/1000.000126.50127.000950.00%
2024/04/090124.3300.00124.000770.00%
2024/03/270.1122.5000.00122.000.1660.15%
2024/03/250123.500123.50124.000620.02%
2024/03/220124.0000.00122.500600.01%
2024/03/210122.5000.00121.500580.03%
2024/03/190.2122.0000.00123.000.2550.36%
2024/03/180.1124.0000.00124.000.1510.24%
2024/03/150.2121.220121.50121.500.2470.37%
2024/03/140.1119.500119.50119.000.1430.23%
2024/03/120117.0000.00117.000380.01%
2024/03/110114.5000.00114.500360.01%
2024/02/1500.000.1111.50112.00-0.131-0.16%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音